This Day On The Street
Continue to site
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here

10 Mid-Cap Stocks Analysts Love

7. Albemarle (ALB - Get Report), a specialty chemicals developer operates in three segments: Polymer Solutions, Catalysts and Fine Chemicals.

Of the 12 analysts covering the stock, 67% recommend a buy and the rest suggest a hold. There are no sell ratings on the stock. On average, analysts polled by Bloomberg estimate 29.9% upside to $62.44 in value from current levels.

For the third quarter of 2011, the company reported net sales of $723 million, compared to $585 million in the year-ago quarter. Net income for the quarter increased to $116.1 million, or $1.28 per diluted share, from $93.7 million, or $1.02 per diluted share, in the third quarter prior year. By segment, catalysts generated 39%, while fine chemicals recorded 30%.

Early November, the company received the Biodiesel Corporation of the Year award from the World Refining Association for successfully developing and commercializing highly engineered basic trans-esterification catalysts for the production of fatty acid methyl-ester biodiesel. The company also has partnered with Southern Microbiological Services to open an R&D microbiology lab in Baton Rouge.

Albemarle, in collaboration with Louisiana State University and the Center for Advanced Microstructures and Devices, has developed a method to increase the 3-D visualization of flame retardant and synergist components using element specific X-ray tomography.

Looking ahead, the company expects business to be fundamentally strong and sees the second half of 2011 tracking the first half of 2011. It expects to end 2011 on a positive note, well positioned for 2012.
4 of 10

Check Out Our Best Services for Investors

Action Alerts PLUS

Portfolio Manager Jim Cramer and Director of Research Jack Mohr reveal their investment tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
Quant Ratings

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
Stocks Under $10

David Peltier uncovers low dollar stocks with serious upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
14-Days Free
Only $9.95
14-Days Free
Dividend Stock Advisor

David Peltier identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Updates with exact steps to take - BUY, HOLD, SELL
Trifecta Stocks

Every recommendation goes through 3 layers of intense scrutiny—quantitative, fundamental and technical analysis—to maximize profit potential and minimize risk.

Product Features:
  • Model Portfolio
  • Intra Day Trade alerts
  • Access to Quant Ratings
Real Money

More than 30 investing pros with skin in the game give you actionable insight and investment ideas.

Product Features:
  • Access to Jim Cramer's daily blog
  • Intraday commentary and news
  • Real-time trading forums
Only $49.95
14-Days Free
14-Days Free
JAH $58.97 0.00%
SFD $0.00 0.00%
WPI $85.73 0.00%
MWV $48.30 2.35%
MCRS $67.99 0.00%


Chart of I:DJI
DOW 17,773.64 -57.12 -0.32%
S&P 500 2,065.30 -10.51 -0.51%
NASDAQ 4,775.3580 -29.9330 -0.62%

Free Reports

Top Rated Stocks Top Rated Funds Top Rated ETFs